Predicting mucosal healing in Crohn's disease: development of a deep-learning model based on intestinal ultrasound images
- PMID: 40522531
- PMCID: PMC12170472
- DOI: 10.1186/s13244-025-02014-5
Predicting mucosal healing in Crohn's disease: development of a deep-learning model based on intestinal ultrasound images
Abstract
Objective: Predicting treatment response in Crohn's disease (CD) is essential for making an optimal therapeutic regimen, but relevant models are lacking. This study aimed to develop a deep learning model based on baseline intestinal ultrasound (IUS) images and clinical information to predict mucosal healing.
Methods: Consecutive CD patients who underwent pretreatment IUS were retrospectively recruited at a tertiary hospital. A total of 1548 IUS images of longitudinal diseased bowel segments were collected and divided into a training cohort and a test cohort. A convolutional neural network model was developed to predict mucosal healing after one year of standardized treatment. The model's efficacy was validated using the five-fold internal cross-validation and further tested in the test cohort.
Results: A total of 190 patients (68.9% men, mean age 32.3 ± 14.1 years) were enrolled, consisting of 1038 IUS images of mucosal healing and 510 images of no mucosal healing. The mean area under the curve in the test cohort was 0.73 (95% CI: 0.68-0.78), with the mean sensitivity of 68.1% (95% CI: 60.5-77.4%), specificity of 69.5% (95% CI: 60.1-77.2%), positive prediction value of 80.0% (95% CI: 74.5-84.9%), negative prediction value of 54.8% (95% CI: 48.0-63.7%). Heat maps showing the deep-learning decision-making process revealed that information from the bowel wall, serous surface, and surrounding mesentery was mainly considered by the model.
Conclusions: We developed a deep learning model based on IUS images to predict mucosal healing in CD with notable accuracy. Further validation and improvement of this model with more multi-center, real-world data are needed.
Critical relevance statement: Predicting treatment response in CD is essential to making an optimal therapeutic regimen. In this study, a deep-learning model using pretreatment ultrasound images and clinical information was generated to predict mucosal healing with an AUC of 0.73.
Key points: Response to medication treatment is highly variable among patients with CD. High-resolution IUS images of the intestinal wall may hide significant characteristics for treatment response. A deep-learning model capable of predicting treatment response was generated using pretreatment IUS images.
Keywords: Crohn’s disease; Deep learning; Intestinal ultrasound.; Outcome prediction.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: The Institutional Review Board (IRB) of Peking Union Medical College Hospital has approved the protocol of the study (No. K4251). Consent for publication: Written informed consent was waived by IRB. Competing interests: This research was partially funded by Birentech. Zheng Cao, who is employed by Birentech, also contributed to the design of the deep learning model. However, none of the other authors have any financial or affiliative relationship with Birentech.
Figures




References
-
- Torres J, Mehandru S, Colombel JF, Peyrin-Biroulet L (2017) Crohn’s disease. Lancet 389:1741–1755 - PubMed
-
- Denson LA, Curran M, McGovern DPB et al (2019) Challenges in IBD research: precision medicine. Inflamm Bowel Dis 25:S31–s39 - PubMed
-
- Reinink AR, Lee TC, Higgins PD (2016) Endoscopic mucosal healing predicts favorable clinical outcomes in inflammatory bowel disease: a meta-analysis. Inflamm Bowel Dis 22:1859–1869 - PubMed
-
- Chen YJ, Chen BL, Liang MJ et al (2022) Longitudinal bowel behavior assessed by bowel ultrasound to predict early response to anti-TNF therapy in patients with Crohn’s disease: a pilot study. Inflamm Bowel Dis 28:S67–S75 - PubMed
-
- Colombel JF, Sandborn WJ, Rutgeerts P et al (2007) Adalimumab for maintenance of clinical response and remission in patients with Crohn’s disease: the CHARM trial. Gastroenterology 132:52–65 - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Medical